EUVIMEDEUVIMED entdecken
Systematische Übersicht

Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review

James E Bates, Tiziana Rancati, Homa Keshavarz, Giovanna Gagliardi, Marianne C Aznar, Rebecca M Howell, Suman Shrestha, Vitali Moiseenko, Ellen Yorke, Saro Armenian, Leontien Kremer, Ming Hui Chen und 4 weitere

International Journal of Radiation Oncology*Biology*Physics · 2024-06 · 119 (2) · 522-532

DOI: 10.1016/j.ijrobp.2023.03.045 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-06. Verfasst von James E Bates und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia. Electronic address: james.edward.bates@emory.edu. Hauptthemen laut MEDLINE: Cancer Survivors, Heart Diseases, Neoplasms, Radiation Injuries. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Cancer Institute, Cancer Research UK, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Radiation therapy (RT) is an essential component in the treatment of many pediatric malignancies. Thoracic RT may expose the heart to radiation dose and thereby increase the risk of late cardiac disease. This comprehensive review from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) initiative focused on late cardiac disease in survivors of childhood cancer treated with RT. METHODS AND MATERIALS: This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology. We identified 1496 articles; 4 were included for dose-response modeling between mean cardiac radiation dose and risk of late coronary artery disease, heart failure (HF), valvular disease, and any cardiac disease. RESULTS: For each 10-Gy increase in corrected mean cardiac radiation dose in 1.8- to 2.0-Gy fractions, we estimated a hazard ratio of 2.01 (95% confidence interval [CI], 1.79-2.25) for coronary artery disease, of 1.87 (95% CI, 1.70-2.06) for HF, of 1.87 (95% CI, 1.78-1.96) for valvular disease, and of 1.88 (95% CI, 1.75-2.03) for any cardiac disease. From the same model, for each 100-mg/m2 increase in cumulative anthracycline dose, the hazard ratio for the development of HF was 1.93 (95% CI, 1.58-2.36), equivalent to an increase in mean heart dose of approximately 10.5 Gy. Other nontreatment factors were inconsistently reported in the analyzed articles. CONCLUSIONS: Radiation dose to the heart increases the risk of late cardiac disease, but survivors of childhood cancer who receive a mean dose

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsHeart DiseasesNeoplasmsRadiation InjuriesChildHumansCoronary Artery DiseaseDose-Response Relationship, RadiationHeartHeart FailureHeart Valve DiseasesRadiotherapy Dosage

Autor:innen und Institutionen

  • Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia. Electronic address: james.edward.bates@emory.edu.
  • Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • University Health Network, Toronto, Ontario, Canada.
  • Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
  • Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas; Graduate School of Biomedical Sciences, MD Anderson UT Health, Houston, Texas.

Förderung

  • National Cancer Institute
  • Cancer Research UK
  • National Institutes of Health
  • University of Oxford
  • Engineering and Physical Sciences Research Council

Zitieren

APA

Bates, J. E., Rancati, T., Keshavarz, H., Gagliardi, G., Aznar, M. C., Howell, R. M., Shrestha, S., Moiseenko, V., Yorke, E., Armenian, S., Kremer, L., Chen, M. H., van der Pal, H. J., Cutter, D. J., Constine, L. S., & Hodgson, D. (2024). Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics, 119(2), 522-532. https://doi.org/10.1016/j.ijrobp.2023.03.045

Vancouver

Bates JE, Rancati T, Keshavarz H, Gagliardi G, Aznar MC, Howell RM, et al. Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. 2024;119(2):522-532. doi:10.1016/j.ijrobp.2023.03.045

BibTeX
@article{Bates2024,
  author = {Bates, James E and Rancati, Tiziana and Keshavarz, Homa and Gagliardi, Giovanna and Aznar, Marianne C and Howell, Rebecca M and Shrestha, Suman and Moiseenko, Vitali and Yorke, Ellen and Armenian, Saro and Kremer, Leontien and Chen, Ming Hui and van der Pal, Helena J and Cutter, David J and Constine, Louis S and Hodgson, David},
  title = {Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2024},
  volume = {119},
  number = {2},
  pages = {522--532},
  doi = {10.1016/j.ijrobp.2023.03.045}
}
Kostenlos starten →